Delcath Systems Stock

Delcath Systems Net Debt

The Net Debt of Delcath Systems (DCTH) as of Aug 17, 2026 is -79.46 M USD. In the previous year, Net Debt was -53.23 M USD — a change of 49.26% (lower).

Net Debt

-79.46 MUSD

YoY

49.26%

Last updated:

Net Debt of Delcath Systems is 2026 -79.46 M USD. Net Debt of Delcath Systems was 2025 -53.23 M USD. It decreases by 49.26% lower compared to the previous year.
Access this data via the Eulerpool API

Delcath Systems Stock analysis

What does Delcath Systems do? Delcath Systems Inc is a US-American medical technology company specializing in the development of innovative products for the treatment of various forms of liver cancer. The company was founded in 1988 in New York and is headquartered in Queensbury today. Delcath Systems is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Delcath Systems stock

Net Debt of Delcath Systems is -79.46 M USD in 2026.

Net Debt of Delcath Systems changed from -53.23 M USD to -79.46 M USD, representing a 49.26% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt Delcath Systems since 2006 – with annual values, charts, and detailed analysis.

Net debt is total debt minus cash and cash equivalents. It shows the actual debt burden after accounting for available liquid resources.

Net Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Debt's Delcath Systems historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Delcath Systems

All Key Metrics — Delcath Systems